CORE SCIENTIFIC, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.755 USD | +7.90% |
|
+18.91% | 0.00% |
| May. 08 | Earnings Flash (CORZ) CORE SCIENTIFIC Posts Q1 Revenue $179.3M | MT |
| May. 08 | Core Scientific, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2024 | 2025 |
|---|---|---|
| Capitalization 1 | 618.7 | - |
| Enterprise Value (EV) 1 | 618.7 | 618.7 |
| P/E ratio | -87 x | 18.8 x |
| Yield | - | - |
| Capitalization / Revenue | 1.25 x | 0.98 x |
| EV / Revenue | 1.25 x | 0.98 x |
| EV / EBITDA | 2.63 x | 2.16 x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Price to Book | - | - |
| Nbr of stocks (in thousands) | 177,783 | - |
| Reference price 2 | 3.480 | 3.480 |
| Announcement Date | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | 544.5 | 640.3 | 502.4 | 493.1 | 630 |
| EBITDA 1 | 238.9 | 174.9 | 170 | 235.4 | 286 |
| EBIT 1 | 166.5 | -2,110 | 8.961 | 17.55 | 99.81 |
| Operating Margin | 30.58% | -329.46% | 1.78% | 3.56% | 15.84% |
| Earnings before Tax (EBT) 1 | 63.08 | -2,163 | -245.8 | -14.48 | 76.8 |
| Net income 1 | 47.31 | -2,146 | -246.5 | -13.53 | 76.1 |
| Net margin | 8.69% | -335.2% | -49.06% | -2.74% | 12.08% |
| EPS 2 | - | - | -0.6500 | -0.0400 | 0.1850 |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 3/29/22 | 4/4/23 | 3/12/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 301.8 | 192.5 | 164 | 162.6 | 121.2 | 120.7 | 126.9 | - | 141.9 | 148.5 | 119.2 | 103.7 | 121.7 | 136.4 |
| EBITDA 1 | 150.9 | 93.04 | 59.11 | 17.54 | 5.175 | 28.66 | 44.82 | - | 57.53 | 86.15 | 47.89 | 38.05 | 63.27 | 62.47 |
| EBIT 1 | 122.4 | 50.9 | -1,095 | -401.4 | -636.1 | -3.695 | 9.384 | - | 3.934 | 31.09 | -7.458 | -20.15 | -4.102 | 17.85 |
| Operating Margin | 40.57% | 26.44% | -667.57% | -246.89% | -524.6% | -3.06% | 7.39% | - | 2.77% | 20.93% | -6.26% | -19.43% | -3.37% | 13.08% |
| Earnings before Tax (EBT) 1 | 76.97 | -423.8 | -908.4 | -424.2 | -456.3 | -11.58 | -9.131 | - | -195.4 | 30.65 | -11.58 | -24.03 | -5.908 | 11.3 |
| Net income 1 | 60.51 | -466.2 | -861.7 | -434.8 | -434.8 | -11.68 | -9.26 | -41.15 | -195.7 | 30.15 | -11.58 | -24.03 | -5.908 | 11.3 |
| Net margin | 20.05% | -242.16% | -525.5% | -267.45% | -358.64% | -9.68% | -7.3% | - | -137.88% | 20.3% | -9.72% | -23.17% | -4.85% | 8.28% |
| EPS 2 | - | - | - | - | - | - | - | - | -0.5100 | 0.1067 | -0.0333 | -0.0933 | -0.0167 | 0.005000 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/29/22 | 5/12/22 | 8/11/22 | 11/22/22 | 4/4/23 | 5/15/23 | 8/4/23 | 11/6/23 | 3/12/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 3/29/22 | 4/4/23 | 3/12/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
3.48
USD
Average target price
6.75
USD
Spread / Average Target
+93.97%
EPS Revisions
- Stock Market
- Equities
- CORZ Stock
- Financials Core Scientific, Inc.